2010 – $81 million settlement for misbranding its anti-epileptic drug Topamax to treat psychiatric disorders and hiring outside physicians to join its sales force to promote the drug for unapproved conditions.

The following year, J&J paid $85 million for similar charges against its heart drug Natrecor

2011 – Several of its baby products were discovered to contain carcinogenic ingredients.

2013 – The US Justice Department charged the company $2.2 billion in criminal fines for marking its autism and anti-psychotic drug Risperdal for unapproved uses. Forty-five states had filed civil lawsuits against J&J in the scandal.

In October 2019, a Philadelphia jury awarded a man $8 billion in punitive damages for failing to warn that the drug could cause young men to grow breasts. Other recent suits include litigation over its blood thinner Xarelto risks of internal bleeding, and a $775 million settlement to 25,000 plaintiffs.

2016 –  Two women were awarded $127 million in damages for the talc in its J&J Baby Powder causing ovarian cancer.  Later, over 1,000 similar cases came forward.

And despite J&J being Purdue’s major supplier, and a major contributor in the US’s opioid epidemic, the latter was forced to file for bankruptcy due to mounting lawsuits for overdose deaths.

Finally, we might ask why a 140 year old company, with no history whatsoever in vaccine development, has now become among the heroes in the immunological war against Covid-19?

vaccineimpact Johnson and Johnson Has Paid $BILLIONS in Criminal Settlements and Never Produced a Vaccine Before – Why Would We Trust Them for a New Experimental COVID Vaccine?